Hyperoxaluria Type
📧 Sign up to get email alerts when something new happens for Hyperoxaluria Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
A prospective observational study of patients with Primary Hyperoxaluria Type 1 (PH1), sponsored by Alnylam, that is currently not recruitin…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) [Phase 1, Phase 2]
Arbor Biotechnologies is conducting a Phase 1/2 trial of ABO-101 for Primary Hyperoxaluria Type 1, and the study is currently recruiting und…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD [Phase 2]
This is a Phase 2 clinical trial update describing the safety and efficacy assessment of DCR-PHXC for Primary Hyperoxaluria Type 1 in patien…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Long Term Extension Study in Patients With Primary Hyperoxaluria [Phase 3]
A Phase 3 long-term extension study in patients with Primary Hyperoxaluria is ongoing but not recruiting, sponsored by Dicerna Pharmaceutica…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1) [EARLY_Phase 1]
This is an early-phase 1 clinical trial evaluating YOLT-203 for primary hyperoxaluria type 1, currently recruiting at RenJi Hospital.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Oxalate Excretion Profile in Patients with a Heterozygous Mutation of the AGXT (alanine-glyoxylate Aminotransferase) Gene [NA]
A recruiting clinical trial studying oxalate excretion in patients with a heterozygous AGXT gene mutation, related to primary hyperoxaluria …
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of stiripentol in patients aged 6 years and older with Primary Hyperoxaluri…